AC

Asymmetry Capital Management

North America, California, United States, San Francisco

Description

Asymmetry Capital Management is a San Francisco-based alternative asset management firm.

Investor Profile

Asymmetry Capital Management has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Post Ipo Equity, Seed rounds (top funding stages).
  • Majority of deals are located in United States, Switzerland, Hong Kong.
  • Strong thematic focus on Biotechnology, Medical, Medical Device.

Stage Focus

  • Series C (40%)
  • Post Ipo Equity (20%)
  • Seed (20%)
  • Series D (20%)

Country Focus

  • United States (40%)
  • Switzerland (20%)
  • Hong Kong (20%)
  • Denmark (20%)

Industry Focus

  • Biotechnology
  • Medical
  • Medical Device
  • Cryptocurrency
  • Gaming
  • Health Care
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Asymmetry Capital Management frequently co-invest with?

CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 2
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 2
DC
North America, Illinois, United States, Chicago
Co-Investments: 2
Northpond Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 2
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 3
Sands Capital Ventures
North America, Virginia, United States, Arlington
Co-Investments: 2
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 2

What are some of recent deals done by Asymmetry Capital Management?

Anichess

Hong Kong, Hong Kong Island, Hong Kong

Anichess develops a decentralized chess game.

CryptocurrencyGaming
SeedJun 22, 2023
Amount Raised: $1,500,000
MoonLake Immunotherapeutics

Zug, Zug, Switzerland

MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.

Biotechnology
Post Ipo EquityApr 6, 2022
Amount Raised: $115,000,000
Dice Therapeutics

San Francisco, California, United States

Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.

BiotechnologyMedicalMedical Device
Series CAug 24, 2021
Amount Raised: $60,000,000
Dice Therapeutics

San Francisco, California, United States

Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.

BiotechnologyMedicalMedical Device
Series CJan 8, 2021
Amount Raised: $80,000,000
Galecto

Copenhagen, Hovedstaden, Denmark

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

BiotechnologyHealth CareHealth Diagnostics
Series DSep 25, 2020
Amount Raised: $64,000,000

Find More Investors Like Asymmetry Capital Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Asymmetry Capital Management | Pipeseed